Ngā hua rapu - Arun Azad
- E whakaatu ana i te 1 - 20 hua o te 51
- Haere ki te Whārangi Whai Ake
-
1
-
2
-
3
-
4
Radiotherapy and immunotherapy: a synergistic effect in cancer care mā Guy‐Anne Turgeon, Andrew Weickhardt, Arun Azad, Benjamin Solomon, Shankar Siva
I whakaputaina 2018Revisão -
5
-
6
Chimeric Antigen Receptor T-Cell Therapy in Metastatic Castrate-Resistant Prostate Cancer mā Omattage Mahasha Perera, Patrick B. Thomas, Gail P. Risbridger, Renea A. Taylor, Arun Azad, Michael S. Hofman, Elizabeth D. Williams, Ian Vela
I whakaputaina 2022Revisão -
7
TALAPRO-3 clinical trial protocol: phase III study of talazoparib plus enzalutamide in metastatic castration-sensitive prostate cancer mā Neeraj Agarwal, Fred Saad, Arun Azad, Joaquı́n Mateo, Nobuaki Matsubara, Neal D. Shore, Jayeta Chakrabarti, Hsiang-Chun Chen, Silvana Lanzalone, Alexander Niyazov, Karim Fizazi
I whakaputaina 2023Artigo -
8
Inhibition of DNA-Dependent Protein Kinase Induces Accelerated Senescence in Irradiated Human Cancer Cells mā Arun Azad, Susan Jackson, Carleen Cullinane, Anthony Natoli, Paul M. Neilsen, David F. Callen, Sauveur-Michel Maira, Wolfgang Hackl, Grant A. McArthur, Benjamin Solomon
I whakaputaina 2011Artigo -
9
Modern paradigms for prostate cancer detection and management mā Isabella SC Williams, Aoife McVey, Sachin Perera, J O’Brien, Louise Kostos, Kenneth Chen, Shankar Siva, Arun Azad, Declan G. Murphy, Veeru Kasivisvanathan, Nathan Lawrentschuk, Mark Frydenberg
I whakaputaina 2022Revisão -
10
Combination Therapies in Locally Advanced and Metastatic Hormone-sensitive Prostate Cancer mā Arun Azad, Louise Kostos, Neeraj Agarwal, Gerhardt Attard, Ian D. Davis, Tanya B. Dorff, Silke Gillessen, Chris Parker, Matthew R. Smith, Christopher J. Sweeney, Bertrand Tombal, Karim Fizazi
I whakaputaina 2025Revisão -
11
Towards Routine Implementation of Liquid Biopsies in Cancer Management: It Is Always Too Early, until Suddenly It Is Too Late mā Maarten J. IJzerman, Jasper de Boer, Arun Azad, Koen Degeling, Joel Geoghegan, Chelsee Hewitt, Frédéric Hollande, Belinda Lee, Yat Ho To, Richard W. Tothill, Gavin Wright, Jeanne Tie, Sarah‐Jane Dawson
I whakaputaina 2021Artigo -
12
AlphaBet: Combination of Radium-223 and [177Lu]Lu-PSMA-I&T in men with metastatic castration-resistant prostate cancer (clinical trial protocol) mā Louise Kostos, James Buteau, Theresa Yeung, Juliana Di Iulio, Jing Xie, Anthony Cardin, Kwang Chin, Brittany Emmerson, Katie L. Owen, Belinda S. Parker, Heidi Fettke, Luc Furic, Arun Azad, Michael S. Hofman
I whakaputaina 2022Artigo -
13
Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: TALAPRO-2 phase III study design mā Neeraj Agarwal, Arun Azad, Neal D. Shore, Joan Carles, André P. Fay, Curtis Dunshee, Lawrence I. Karsh, M. Luisa Paccagnella, Nicola Di Santo, Mohamed Elmeliegy, Xun Lin, Akos Czibere, Karim Fizazi
I whakaputaina 2022Artigo -
14
Plain language summary of the design of the TALAPRO-2 study comparing talazoparib and enzalutamide versus enzalutamide and placebo in men with metastatic castration-resistant prost... mā Neeraj Agarwal, Arun Azad, Neal D. Shore, Joan Carles, André P. Fay, Curtis Dunshee, Lawrence I. Karsh, M. Luisa Paccagnella, Nicola Di Santo, Mohamed Elmeliegy, Xun Lin, Akos Czibere, Karim Fizazi
I whakaputaina 2022Artigo -
15
Dual Targeting of the Epidermal Growth Factor Receptor Using the Combination of Cetuximab and Erlotinib: Preclinical Evaluation and Results of the Phase II DUX Study in Chemotherap... mā Andrew Weickhardt, Timothy Price, Geoff Chong, Val Gebski, Nick Pavlakis, Terrance G. Johns, Arun Azad, Effie Skrinos, Kate Fluck, Alexander Dobrovic, Renato Salemi, Andrew M. Scott, John M. Mariadason, Niall C. Tebbutt
I whakaputaina 2012Artigo -
16
TheraP: a randomized phase 2 trial of <sup>177</sup>Lu‐<scp>PSMA</scp>‐617 theranostic treatment vs cabazitaxel in progressive metastatic castration‐resistant prostate cancer (Clin... mā Michael S. Hofman, Louise Emmett, John Violet, Alison Y. Zhang, Nicola Jane Lawrence, Martin R. Stockler, Roslyn J. Francis, Amir Iravani, Scott Williams, Arun Azad, Andrew Martin, Margaret McJannett, Ian D. Davis
I whakaputaina 2019Artigo -
17
Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer mā Manish Kohli, Winston Tan, Tiantian Zheng, Amy Wang, Carlos Montesinos, Calven Wong, Pan Du, Shidong Jia, Siddhartha Yadav, Lisa G. Horvath, Kate Mahon, Edmond M. Kwan, Heidi Fettke, Jianjun Yu, Arun Azad
I whakaputaina 2020Artigo -
18
Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients mā Nada Lallous, Stanislav Volik, Shannon Awrey, Eric Leblanc, Ronnie Tse, Josef Murillo, Kriti Singh, Arun Azad, Alexander W. Wyatt, Stéphane LeBihan, Kim N., Martin Gleave, Paul S. Rennie, Colin C. Collins, Artem Cherkasov
I whakaputaina 2016Artigo -
19
UpFrontPSMA: a randomized phase 2 study of sequential <sup>177</sup>Lu‐PSMA‐617 and docetaxel vs docetaxel in metastatic hormone‐naïve prostate cancer (clinical trial protocol)... mā Nattakorn Dhiantravan, Louise Emmett, Anthony M. Joshua, David A. Pattison, Roslyn J. Francis, Scott Williams, Shahneen Sandhu, Ian D. Davis, Ian Vela, Nitika Neha, Mathias Bressel, Declan G. Murphy, Michael S. Hofman, Arun Azad
I whakaputaina 2021Artigo -
20
A Phase III, Randomized, Open-Label Study (CONTACT-02) of Cabozantinib Plus Atezolizumab Versus Second Novel Hormone Therapy in Patients with Metastatic Castration-Resistant Prosta... mā Neeraj Agarwal, Arun Azad, Joan Carles, Simon Chowdhury, Bradley A. McGregor, Axel S. Merseburger, Stéphane Oudard, Fred Saad, Andrey Soares, Fawzi Benzaghou, Yannick Kerloëguen, Akiko Kimura, Nehal Mohamed, Ashok Panneerselvam, Fong Wang, Sumanta K. Pal
I whakaputaina 2022Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Internal medicine
Cancer
Prostate cancer
Oncology
Androgen receptor
Enzalutamide
Biology
Cancer research
Pathology
Androgen deprivation therapy
Alternative medicine
Placebo
Prostate
Genetics
Docetaxel
Gene
Clinical trial
Urology
Chemotherapy
Clinical endpoint
Confidence interval
Hazard ratio
Randomized controlled trial
Glutamate carboxypeptidase II
Radiology
Abiraterone
Biochemistry
Hormone
Immunology